Which Conditions Contributing to the Charlson Score Predict Survival After Radical Prostatectomy?
- 1 February 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 171 (2), 697-699
- https://doi.org/10.1097/01.ju.0000108138.36333.09
Abstract
The Charlson score is likely to be the most frequently used comorbidity measure in prostate cancer. However, to our knowledge the individual prognostic significance of contributing conditions has not been previously studied in a radical prostatectomy sample. A total of 444 consecutive patients were entered into this study. The 19 conditions contributing to the Charlson score were obtained from the preoperative cardiopulmonary risk assessment and the hospital discharge document. Mantel-Haenszel hazard ratios were estimated for comorbid (noncancer) and overall survival. Thereafter, the Charlson score was refined by excluding conditions with low predictive value. Mean followup was 5.9 years. Only 3 single conditions (congestive heart failure, peripheral vascular disease and severe renal disease) were significantly associated with excess overall mortality. Concerning comorbid mortality, in addition to these 3 diseases, chronic pulmonary disease was associated with increased risk. Refinement of the Charlson score improved the circumscription of patients at risk for premature death after radical prostatectomy. This study suggests that restricting the Charlson score to some clinically meaningful diseases may increase its usefulness in candidates for radical prostatectomy. The conventional Charlson score did not add clinically meaningful information supplementary to congestive heart failure, which is the most important single contributing condition.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomyUrology, 2003
- Sociodemographic and Clinical Risk Characteristics of Patients With Prostate Cancer Within the Veterans Affairs Health Care System: Data From CaPSUREJournal of Urology, 2003
- The Impact Of Co-morbid Disease on Cancer Control and Survival Following Radical CystectomyJournal of Urology, 2003
- A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2002
- Competing Risk Analysis After Radical Prostatectomy for Clinically Nonmetastatic Prostate Adenocarcinoma According to Clinical Gleason Score and Patient AgeJournal of Urology, 2002
- Hormone Therapy for Locally Advanced Prostate CancerJournal of Urology, 2002
- Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant managementCancer, 2001
- Co-Morbidities and Survival of Men with Localized Prostate Cancer Treated with Surgery or Radiation TherapyJournal of Urology, 1996
- The Impact of Co-morbidity on Life Expectancy Among Men with Localized Prostate CancerJournal of Urology, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987